Hasbro (HAS) Shareholders Re-Elect All Directors at Annual Meeting

Hasbro, Inc. (NASDAQ: HAS), a global play and entertainment company, today announced the preliminary results at the 2022 Annual Meeting of Shareholders, as provided by its proxy solicitors, which indicate that Hasbro shareholders have voted, with a substantial margin, to re-elect all 13 of Hasbro’s highly qualified directors to the Hasbro Board: Richard Stoddart, Kenneth Bronfin, Michael Burns, Hope Cochran, Chris Cocks, Lisa Gersh, Elizabeth Hamren, Blake Jorgensen, Tracy Leinbach, Edward Philip, Laurel Richie, Mary Beth West and Linda Zecher Higgins. Similarly, the Company’s say-on-pay proposal and auditor ratification were approved by the shareholders.

The Company issued the following statement, which can also be found, along with other information about the 2022 Annual Meeting, at www.HasbroGamePlan.com.

Hasbro’s Board of Directors would like to thank our shareholders for their continued support and engagement, as well as the invaluable views and perspectives they have shared with us over these last several months. As the vote indicates, our highly skilled and recently refreshed Board possesses experience and expertise directly relevant to overseeing Hasbro’s world class portfolio of assets across multiple play and entertainment categories. Our directors will be instrumental to Chris as he undertakes a strategic review of the business and outlines our go-forward strategy to position Hasbro for long-term success and delivery of shareholder value. We know we have important work ahead of us, and you will be hearing from us as we continue to actively engage with our shareholders.

The results announced today are considered preliminary and are subject to certification by the Independent Inspector of Election. The final results of the 2022 Annual Meeting will be available in a Current Report on Form 8-K filed with the Securities and Exchange Commission and on Hasbro’s investor relations website within the next four business days.

You May Also Be Interested In

• Richard Lowenthal resigns from ARS Pharmaceuticals board
• Huadi International gets Nasdaq minimum bid price deficiency notice
• JCP&L launches exchange offer for $350 million in senior notes due 2030